170 related articles for article (PubMed ID: 37737023)
21. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
22. Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.
Jaeckle KA
Cancer Treat Res; 2005; 125():181-93. PubMed ID: 16211890
[TBL] [Abstract][Full Text] [Related]
23. Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.
Berg SL; Chamberlain MC
Curr Oncol Rep; 2003 Jan; 5(1):29-40. PubMed ID: 12493148
[TBL] [Abstract][Full Text] [Related]
24. New strategies in the management of leptomeningeal metastases.
Groves MD
Arch Neurol; 2010 Mar; 67(3):305-12. PubMed ID: 20212228
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors.
Waki F; Ando M; Takashima A; Yonemori K; Nokihara H; Miyake M; Tateishi U; Tsuta K; Shimada Y; Fujiwara Y; Tamura T
J Neurooncol; 2009 Jun; 93(2):205-12. PubMed ID: 19043775
[TBL] [Abstract][Full Text] [Related]
26. Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?
Siegal T
J Neurooncol; 1998; 38(2-3):151-7. PubMed ID: 9696366
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
28. Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.
Jamison T; Haque E; Muhsen IN; Samarkandi H; Fakih RE; Aljurf M
Med Oncol; 2024 Jun; 41(7):177. PubMed ID: 38884819
[TBL] [Abstract][Full Text] [Related]
29. Leptomeningeal metastases in the MRI era.
Clarke JL; Perez HR; Jacks LM; Panageas KS; Deangelis LM
Neurology; 2010 May; 74(18):1449-54. PubMed ID: 20439847
[TBL] [Abstract][Full Text] [Related]
30. Leptomeningeal metastasis.
Taillibert S; Chamberlain MC
Handb Clin Neurol; 2018; 149():169-204. PubMed ID: 29307353
[TBL] [Abstract][Full Text] [Related]
31. Durable Response of Leptomeningeal Metastasis of Breast Cancer to Salvage Intrathecal Etoposide After Methotrexate: A Case Report and Literature Review.
Park MJ
Am J Case Rep; 2015 Aug; 16():524-7. PubMed ID: 26258900
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma.
Edwards MS; Levin VA; Seager ML; Wilson CB
Childs Brain; 1981; 8(6):444-51. PubMed ID: 6796342
[TBL] [Abstract][Full Text] [Related]
34. [Leptomeningeal carcinomatous metastases].
Mauro A
Minerva Med; 1984 May; 75(22-23):1395-9. PubMed ID: 6547214
[TBL] [Abstract][Full Text] [Related]
35. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
Fleischhack G; Jaehde U; Bode U
Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
[TBL] [Abstract][Full Text] [Related]
37. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
[TBL] [Abstract][Full Text] [Related]
38. Leptomeningeal metastases: the future is now.
Lukas RV; Thakkar JP; Cristofanilli M; Chandra S; Sosman JA; Patel JD; Kumthekar P; Stupp R; Lesniak MS
J Neurooncol; 2022 Feb; 156(3):443-452. PubMed ID: 35048267
[TBL] [Abstract][Full Text] [Related]
39. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
